Srivastava, Arun

Nucleotide sequence and organization of the adeno-associated virus 2 genome

Srivastava, A., Lusby, E. W., & Berns, K. I. (1983) · Journal of Virology

Virus-based gene therapy researchVirology and Viral Diseases

Cited by 721

Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses

Zhong, L., Li, B., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R. W., Zolotukhin, I., Warrington, K. H., Weigel-Van Aken, K. A., et al. (2008) · Proceedings of the National Academy of Sciences

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 558

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2

Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 443

High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors

Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 398

Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV

Samulski, R. J., Srivastava, A., Berns, K. I., & Muzyczka, N. (1983) · Cell

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 297

Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina

Petrs-Silva, H., Dinculescu, A., Li, Q., Deng, W.-T., Pang, J.-J., Min, S.-H., Chiodo, V., Neeley, A. W., Govindasamy, L., Bennett, A., et al. (2011) · Molecular Therapy

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 267

Capsid modifications for targeting and improving the efficacy of AAV vectors

Büning, H., & Srivastava, A. (2019) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 260

Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression

Zhong, L., Li, B., Jayandharan, G., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Herzog, R. W., Weigel-Van Aken, K. A., Hobbs, J. A., Zolotukhin, S., et al. (2008) · Virology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 232

Innate Immune Responses to AAV Vectors

Rogers, G. L., Martino, A. T., Aslanidi, G. V., Jayandharan, G. R., Srivastava, A., & Herzog, R. W. (2011) · Frontiers in Microbiology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 178

Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells

Martino, A. T., Basner-Tschakarjan, E., Markusic, D. M., Finn, J. D., Hinderer, C., Zhou, S., Ostrov, D. A., Srivastava, A., Ertl, H. C. J., Terhorst, C., et al. (2013) · Blood

Virus-based gene therapy researchHemophilia Treatment and Research

Cited by 162

High-efficiency transduction and correction of murine hemophilia b using AAV2 vectors devoid of multiple surface-exposed tyrosines

Markusic, D. M., Herzog, R. W., Aslanidi, G. V., Hoffman, B. E., Li, B., Li, M., Jayandharan, G. R., Ling, C., Zolotukhin, I., Ma, W., et al. (2010) · Molecular Therapy

Virus-based gene therapy researchHemophilia Treatment and Research

Cited by 131

Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells

Rogers, G. L., Shirley, J. L., Zolotukhin, I., Kumar, S. R. P., Sherman, A., Perrin, G. Q., Hoffman, B. E., Srivastava, A., Basner-Tschakarjan, E., Wallet, M. A., et al. (2017) · Blood

Immunotherapy and Immune ResponsesVirus-based gene therapy research

Cited by 131

Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts

Hansen, J., Qing, K., & Srivastava, A. (2001) · Journal of Virology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 129

Adeno-Associated Virus Type 2-Mediated Gene Transfer: Role of Cellular FKBP52 Protein in Transgene Expression

Qing, K., Hansen, J., Weigel-Kelley, K. A., Tan, M., Zhou, S., & Srivastava, A. (2001) · Journal of Virology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 126

FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform

Yang, Z., Wolf, I. M., Chen, H., Periyasamy, S., Chen, Z., Yong, W., Shi, S., Zhao, W., Xu, J., Srivastava, A., et al. (2006) · Molecular Endocrinology

Estrogen and related hormone effectsReproductive System and Pregnancy

Cited by 119

Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid

Vercauteren, K., Hoffman, B. E., Zolotukhin, I., Keeler, G. D., Xiao, J. W., Basner-Tschakarjan, E., High, K. A., Ertl, H. C., Rice, C. M., Srivastava, A., et al. (2016) · Molecular Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 114

Self-Complementary Recombinant Adeno-Associated Viral Vectors: Packaging Capacity And The Role of Rep Proteins in Vector Purity

Wu, J., Zhao, W., Zhong, L., Han, Z., Li, B., Ma, W., Weigel-Kelley, K. A., Warrington, K. H., & Srivastava, A. (2007) · Human Gene Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 108

Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions

Wang, X. S., Ponnazhagan, S., & Srivastava, A. (1996) · Journal of Virology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 104

Rescue and Replication Signals of the Adeno-associated Virus 2 Genome

Wang, X.-S., Ponnazhagan, S., & Srivastava, A. (1995) · Journal of Molecular Biology

Virus-based gene therapy researchParvovirus B19 Infection Studies

Cited by 66

Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats

Wang, X. S., Qing, K., Ponnazhagan, S., & Srivastava, A. (1997) · Journal of Virology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 61

Enhanced Transgene Expression from Recombinant Single-Stranded D-Sequence-Substituted Adeno-Associated Virus Vectors in Human Cell Lines In Vitro and in Murine Hepatocytes In Vivo

Ling, C., Wang, Y., Lu, Y., Wang, L., Jayandharan, G. R., Aslanidi, G. V., Li, B., Cheng, B., Ma, W., Lentz, T., et al. (2015) · Journal of Virology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 47

Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune Response

Kwon, H.-J., Qing, K., Ponnazhagan, S., Wang, X.-S., Markusic, D. M., Gupte, S., Boye, S. E., & Srivastava, A. (2020) · Human Gene Therapy

Virus-based gene therapy researchImmunotherapy and Immune Responses

Cited by 6

Gene Therapy with Viral Vectors: The Hope, the Problems, and the Solution

Srivastava, A. (2001) · Journal of Hematotherapy & Stem Cell Research

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 4